Table 3 Monitoring of Patients Experiencing HF (N = 31)
Ejection Fraction | Presentation N (%) | Follow-Up N (%) |
|---|---|---|
≤40% | 14 (45.2) | 8 (25.8) |
41–49% | 5 (16.1) | 2 (6.5) |
≥ 50% | 10 (32.3) | 8 (25.8) |
Not Available | 2 (6.5) | 13 (41.9) |
Median time to follow-up (days) | 89 (IQR 32.25-188.25) | |
BNP | ||
Elevated BNP, N (%) | 24 (77.4) | |
Median BNP at presentation (pg/mL) | 486 (IQR 208–957) | |
Median pre-discharge BNP (pg/mL)* | 340 (IQR 147.5–774) | |
Median time to follow-up BNP (days)** | 49 (IQR 23–130) | |
Median BNP at follow-up (pg/mL) | 412 (IQR 202–836) | |